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Monocytes play an essential role in the defense against bacterial pathogens. Bone marrow (BM) and peripheral
blood (PB) monocytes in pigs consist of the main “steady-state” subpopulations: CD14hi/CD163-/SLA-DR- and
CD14low/CD163+/SLA-DR+. During inflammation, the subpopulation of “inflammatory” monocytes expressing very
high levels of CD163, but lacking the SLA-DR molecule (being CD14low/CD163+/SLA-DR-) appears in the BM and PB
and replaces the CD14low/CD163+/SLA-DR+ subpopulation. However, current knowledge of monocyte migration
into inflamed tissues in pigs is limited. The aim of the present study was to evaluate the distribution of
“inflammatory” CD14low/CD163+/SLA-DR- monocytes during experimental inflammation induced by Actinobacillus
pleuropneumoniae (APP) and a possible role for chemokines in attracting “inflammatory” CD14low/CD163+/SLA-DR-
monocytes into the tissues. Monocyte subpopulations were detected by flow cytometry. Chemokines and
chemokine receptors were detected by RT-qPCR. The “steady-state” monocytes were found in the BM, PB, spleen
and lungs of control pigs. After APP-infection, “inflammatory” monocytes replaced the “steady-state” subpopulation
in BM, PB, spleen and moreover, they appeared in an unaffected area, demarcation zone and necrotic area of the
lungs and in tracheobronchial lymph nodes. They did not appear in mesenteric lymph nodes. Levels of mRNA for
various chemokines with their appropriate receptors were found to be elevated in BM (CCL3-CCR1/CCR5, CCL8-
CCR2/CCR5, CCL19-CCR7), necrotic area of the lungs (CCL3-CCR1, CCL5-CCR1/CCR3, CCL11-CCR3, CCL22/CCR4) and
tracheobronchial lymph nodes (CCL3-CCR1) and therefore they could play a role in attracting monocytes into
inflamed tissues. In conclusion, “inflammatory” monocytes appear in different lymphoid tissues and the lungs after
APP infection in pigs. Various chemokines could drive this process.Introduction
Monocytes are cells of nonspecific immunity which play
an essential role in the defense against bacterial patho-
gens [1]. Monocytes originate from bone marrow (BM).
Monocytes from the BM enter blood circulation and
from there they migrate to various tissues. Thereafter,
they can undergo further differentiation into macro-
phages or dendritic cells (DC) during inflammation
[2,3]. Moreover, monocytes themselves can infiltrate the
site of inflammation and subsequently the draining
lymph nodes (LN) where they present the antigen as
monocyte-derived dendritic cells [2,4]. Recent findings* Correspondence: faldyna@vri.cz
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distribution, and reproduction in any mediumshow that monocytes are also capable of transporting
the antigen from the tissue to the LN [5,6] where they
efficiently present the antigen to T cells as they are, i.e.
without subsequent development into DC [7].
An ambivalent role is attributed to the spleen in mono-
cyte trafficking. Monocytes recruited into the spleen during
inflammation play an important role in the control of the
infection as they are [8] or they can develop into a special-
ized subset of DC (the TipDC) which play a crucial role in
controlling pathogen burden [3]. The spleen, however, is
populated with monocytes, also under steady-state condi-
tions, serving as a rapid source of monocytes in the event
of their sudden need [9].ntral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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from PB to inflamed tissues and LN in mice is driven by
chemokines, chemokine receptors [10-12], adhesion
molecules [13] and other factors [14]. Monocytes are
mobilized from the BM to the PB via CCR2-CCL2/
CCL7 signaling [15]. The role of CCR2-CCL2 signaling
is controversial, while other chemokines and their recep-
tors such as CCL3, CCL4, CCR1 and CCR5 may drive
migration of monocytes from PB to the tissues in
humans and mice [11,12] [16]. Control of monocyte re-
lease from the spleen in mice is rather specific because
it is controlled by angiotensin II signaling [14].
Blood monocytes in various species consist of several
subpopulations of cells differing in size, nuclear morph-
ology, granularity, and functionality [17]. Based on the
expression of cell surface molecules CD14, CD163 and
SLA-DR, two major “steady-state” subpopulations of
BM and PB monocytes have been described in pigs:
CD14hi/CD163-/SLA-DR- and CD14low/CD163+/SLA-
DR+ monocytes [18]. During inflammation, the large
subpopulation of “inflammatory” monocytes expressing
very high levels of CD163, but probably lacking the
SLA-DR molecule (thus being CD14low/CD163+/SLA-
DR-), rapidly appear in the BM and PB and replace the
CD14low/CD163+/SLA-DR+ subpopulation [19].
Although the pig serves as an important animal model
for understanding innate human immunity [20], the
current knowledge of monocyte migration into inflamed
tissues is limited.
Actinobacillus pleuropneumoniae (APP) is the causa-
tive agent inducing pleuropneumonia in pigs. The bac-
teria bind to cells of the lower respiratory tract [21].
Clinical signs and pathological changes of the disease
already appear within a few hours after experimental in-
fection [22]. The infection is followed by the destruction
of alveolar macrophages and a rapid influx of profes-
sional phagocytes and lymphocytes to the tissue and
bronchoalveolar space [22]. A rapid cellular influx of MP
into infected lungs together with a specific localization
of the pathogen in the lungs predetermine experimental
APP infection to be an appropriate model for observing
MP migration under inflammatory conditions in pigs. It
was previously demonstrated that porcine monocytes
migrate into the lungs during inflammation induced by
Actinobacillus pleuropneumoniae [19] where they be-
come a source of pro-inflammatory cytokines (our un-
published data) and after a few days they probably
develop into macrophages [19]. The role of chemokines
and their receptors in monocyte trafficking in pigs is
completely unknown.
The present study reveals that CD163+ monocytes in-
filtrate various tissues during inflammation. Moreover,
changes in mRNA levels of chemokines and chemokine
receptors during this process are demonstrated.Material and methods
Animals
Fifteen eight-week-old healthy pigs from a herd with no
history of APP infection or vaccination were used in the
experiment. The pigs were kept in the accredited
barrier-type animal facilities of the Veterinary Research
Institute, Brno. The animal care protocol for this experi-
ment followed the Czech guidelines for animal experi-
mentation and was approved by the Branch Commission
for Animal Welfare of the Ministry of Agriculture of the
Czech Republic (permission No MZe 1223). The pigs
were allowed to acclimatize in the animal facilities for
two weeks before the experimental infection was
performed.
Nine pigs were exposed to APP infection for 18 h and
six pigs served as non-infected controls. The infection
with an APP field strain (biotype 1, serotype 9, KL2-
2000) from the fourth passage was performed intrana-
sally during inhalation, administering 5 × 108 bacteria
suspended in phosphate buffered saline to the second
third of each nasal cavity. Health status was monitored
during the entire experiment and clinical signs of re-
spiratory disorders were recorded (dyspnoea, cough, an-
orexia, depression and lethargy).
Euthanasia was performed by exsanguination after com-
bined anesthesia with a TKX (Telazol-Ketamin-Xylazin)
mixture containing 12.5 mg/mL tiletamine and 12.5 mg/mL
zolazepam (Telazol, Virbac, Carros, France), 12.5 mg/mL
ketamine (Vetoquinol, Lure, France) and 12.5 mg/mL
xylazine (Bioveta, Ivanovice na Hane, Czech Republic), ad-
ministered intramuscularly in a final volume of 0.2 mL/kg
body weight.
Blood and tissue sampling and processing
Heparinized peripheral blood (PB) samples in a total vol-
ume of 250 mL per pig were collected during euthanasia
into 50 mL polypropylene tubes (TPP, Trasadingen,
Switzerland). Moreover, BM, spleen, lung, tracheobron-
chial lymph node (TBLN) and mesenteric lymph node
(MLN) samples were taken immediately after euthanasia.
Samples were taken from the lungs of infected animals
from three different sites as described previously [23]:
(1) necrotic area (NA), (2) demarcation zone (DZ), and
(3) visually unaffected area (UA). The samples were used
for isolation of leukocytes that subsequently underwent
flow cytometric analysis (BM, PB, spleen, lungs, TBLN,
MLN) and cell sorting (BM, PB). A part of the tissue sam-
ples was frozen in liquid nitrogen and stored at −80 °C
until further use for immunohistochemical staining. A part
of tissue samples was placed into RNAlater, left at 4 °C
overnight and then stored at −80 °C until further process-
ing for RT-qPCR analysis.
The suspension of BM leukocytes was acquired as fol-
lows: the sternum bones were separated from the
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collected by washing the bone tissue with pyrogen-free
DPBS (Dulbecco’s Phosphate Buffered Saline, Sigma-
Aldrich, St. Louis, USA). The suspension of splenic, lung
(NA, DZ and UA), TBLN and MLN leukocytes was ac-
quired as follows: a piece of the tissue was weighed, cut
into small pieces (less than 1 mm3) and then the pieces
were disintegrated by passing through a fine nylon mesh.
Finally, the isolated BM, splenic, lung, TBLN and MLN
leukocytes were washed with DPBS (centrifugation speed
626 g).
Then, concentration of leukocytes per mL of PB was
assessed using an auto hematology analyzer (BC-2800Vet,
Shenzhen Mindray Bio-Medical Electronics, Shenzhen,
People’s Republic of China). Moreover, the total counts of
the isolated BM, splenic, lung, TBLN and MLN leukocytes
were assessed using the auto hematology analyzer and, to-
gether with the known original weight of the tissue from
which the cells were isolated, the total leukocyte count
per g of the tissue was calculated.
Detection of cell surface molecules by flow cytometry
Staining of cell surface molecules was performed as de-
scribed previously [18], with small modifications. Samples of
BM, splenic, lung, TBLN or MLN leukocytes were lysed
with ammonium chloride solution in order to remove con-
taminating red blood cells, washed, pelleted and stained with
a cocktail of the following anti-CD antibodies: anti-CD203a
(clone PM 18–7, IgG1 subclass, Serotec, Oxford, UK), anti-
SLA-DR (clone MSA3, IgG2a subclass, VMRD, Pullman,
USA), anti-CD14 (clone MIL-2, IgG2b subclass, Serotec,
Oxford, UK), anti-SWC8 (clone MIL-3, IgM class, a gener-
ous gift from Dr J.K. Lunney, Animal Parasitology Institute,
Beltsville, MO, USA) in the presence of heat-inactivated goat
serum. Then, staining with a cocktail containing the follow-
ing secondary antibodies was performed: anti-mouse IgG1:
PE (Southern Biotech, Birmingham, USA), anti-mouse
IgG2a: PE-Cy5.5 (Invitrogen, Carlsbad, USA), anti-mouse
IgG2b: SPRD (Southern Biotech, Birmingham, USA) and
anti-IgM: DyLight405 (Jackson ImmunoResearch Laborator-
ies, West Grove, USA). Then, incubation with heat
inactivated mouse serum was performed. After that, samples
were stained with anti-CD172a (clone DH59B, IgG1 sub-
class, VMRD, Pullman, USA) pre-labeled with Zenon
mouse-IgG1: Alexa Fluor 647 reagent (Invitrogen, Carlsbad,
USA) and with anti-CD163 (clone 2A10/11, IgG1 subclass,
Serotec, Oxford, UK) pre-labeled with Zenon mouse-IgG1:
Alexa Fluor 488 (Invitrogen, Carlsbad, USA) and with
propidium iodide (PI, Sigma-Aldrich, St. Louis, USA). The
measurement was performed by the BD LSRFortessa cell
analyzer (Becton-Dickinson, San Jose, USA). Three hundred
thousand events were acquired. The post-acquisition ana-
lysis of data was performed using BD FACSDiva software
(Becton-Dickinson, San Jose, USA).The monocytes and macrophages were identified as de-
scribed previously [19]. The general gating strategy is
shown in Figure 1A. Then, two major monocyte subpopu-
lations were identified according to CD14 and CD163
expression as CD14hi/CD163- and CD14low/CD163+ mono-
cytes. The total counts of monocytes in PB and various tis-
sues were calculated using previously determined total
leukocyte count per mL of PB or per g of the tissue. More-
over, intensity (median of fluorescence intensity, MFI) of
CD163, CD14 and SLA-DR expression was ascertained in
CD14low/CD163+ monocytes.
Immunohistochemistry
Frozen tissue samples were cut using a cryostat (CM1900,
Leica Microsystems GmbH, Wetzlar, Germany), placed on
Vectabond-covered slides (Vector Laboratories, Burlin-
game, USA), fixed with acetone at −20 °C, dried, and stored
at −20 °C until subsequent staining. The endogenous per-
oxidase was quenched with Dual Endogenous Enzyme-
Blocking Reagent (DAKO, Glostrup, Denmark) for 10 min.
Slides were washed and the Protein Block (DAKO,
Glostrup, Denmark) was applied for 5 min. Then, anti-
CD163 antibody was applied and the slides were incubated
for 60 min at 37 °C in a humid chamber. Then, the slides
were washed and EnVision reagent (HRP, Mouse, DAKO)
was added. The slides were incubated for 60 min at 37 °C
in a humid chamber. The slides were washed and stained
with DAB+ (Liquid, DAKO, Glostrup, Denmark) for
approx. 1–3 min. Then, the slides were washed with dis-
tilled water, lightly counterstained with Harris hematoxylin
and mounted in glycerol-gelatin.
Cell sorting
The CD163+ monocytes from APP-infected and control
pigs were sorted. BM and PB mononuclear cells, freshly
isolated from BM and PB samples by Lympholyte-H gradi-
ent (Cedarlane, Burlington, Canada) centrifugation at 800 g,
were labeled with anti-CD163 antibody for 15 min at 4 °C.
Then, they were thoroughly rinsed and incubated with
Anti-Mouse IgG Micro Beads (Miltenyi Biotec, Bergisch
Gladbach, Germany) for 20 min at 4 °C. The labeled
cells were passed through MACS LS Separation Columns
using Quadro Macs Separator (Miltenyi Biotec, Bergisch
Gladbach, Germany) and CD163+ monocytes were col-
lected. The purity of the collected CD163+ monocytes was
evaluated by flow cytometry and was found to be higher
than 95%. The cells were pelleted immediately after
sorting, lysed with RLT buffer (Qiagen, Hilden, Germany)
and stored at −80 °C until processing.
Quantitative real-time PCR
The isolation of total RNA and quantitative real-time
PCR analysis was performed as described previously
[24]. Primers for the genes were designed using the
Figure 1 (See legend on next page.)
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Figure 1 Overview of flow cytometry analyses. (A) Gating strategy for identification of monocytes and macrophages. The peripheral blood is
shown. Designation of population shown within each dot-plot is indicated above the dot-plot. Leukocytes were identified as viable (a) non-
doublet (b) cells with typical light scatter properties of leukocytes (c). Then, macrophages were gated simply as CD203ahi leukocytes (d) and
marked with blue color. Monocytes were gated as CD203alow/- SWC8- (e) CD172ahi (f) leukocytes where the CD203alow/- region was defined as
the complementary region to the CD203ahi region. Then, SLA-DR+ monocytes were marked with red color and SLA-DR- monocytes were marked
with green color (g). SLA-DR- region was defined as the complementary region to the SLA-DR+ region. Gating order is shown in the scheme (h).
(B) Representative CD163 vs. CD14 dot-plots of macrophages (blue) and monocyte subpopulations (green: SLA-DR–, red: SLA-DR+) in various
body compartments of control and APP-infected pigs.
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annealing temperature was 58 °C. The specificity of real-
time PCR was evaluated by analysis of Tm. Expression
of each gene was calculated as a multiple of the refer-
ence gene expression using the following formula: [1/
(ECtGene)]/ [1/(ECtReference Gene)] where E represents the
amplification efficiency of the primer pair used. Amplifica-
tion efficiency was higher than 1.95 for each gene. The data
are expressed in relation to the reference gene Hypoxan-
thine-guaninephosphoribosyltransferase (HPRT) [26].
Statistical analysis
Statistical evaluation of data was performed by the
Mann–Whitney U test. The differences in CD163, CD14
and SLA-DR molecule expression in various organs was
evaluated by the Kruskal-Wallis test and Dunn’s post-
test (GraphPad Prism, Version 3.02, GraphPad Software,
San Diego, USA).
Results
Distribution and phenotypic characterization of CD14hi/
CD163- and CD14low/CD163+ monocytes from various
organs
The appearance of CD14hi/CD163- and CD14low/CD163+
monocytes was evaluated in BM, PB, spleen, lungs, TBLN
and MLN from control and APP-infected pigs by flow
cytometry.
The monocytes from control pigs were found in BM,
PB, spleen and lungs (Figure 1B). No monocytes were
found in TBLN and MLN. In conformity with our previ-
ous study [18], CD14hi/CD163- monocytes were almost
exclusively SLA-DR- while CD14low/CD163+ monocytes
were mostly SLA-DR+.
After APP infection, monocytes were still present in
BM, PB, spleen and UA of the lungs. Moreover, they
appeared in DZ as well as in NA of lungs. Although they
massively infiltrated TBLN, they did not appear in MLN,
suggesting that monocytes appeared specifically in the
LN, which drain the inflamed tissue. The CD14low/
CD163+ monocytes from infected pigs were almost ex-
clusively SLA-DR- and show much higher expression of
CD163 on the contrary to CD14low/CD163+ monocytes
from control pigs and consistently with our previous
findings [19]. Because the CD14low/CD163+ monocytescreated during APP-induced inflammation differed
markedly from CD14low/CD163+ monocytes in control
pigs, we hereinafter call them “inflammatory” and
“steady-state” monocytes, respectively.
Then, total counts of monocyte subpopulations and
lung macrophages per mL of PB or per g of tissue were
calculated. The numbers of CD14hi/CD163- monocytes
in BM, PB and UA of the lungs and spleen decreased
after infection and they were not elevated in either organ
except a small population in TBLN (Table 2). On the
contrary, the numbers of CD14low/CD163+ monocytes
were elevated in PB and the UA of the lungs and, more-
over, monocytes massively appeared in TBLN. On the
contrary, their counts did not change significantly in
BM, DZ and NA of the lungs and in the spleen.
The counts of lung macrophages were not changed
significantly in UA and DZ of lungs from APP-infected
pigs when compared to controls. On the contrary, lung
macrophages almost completely disappeared in the NA
of the lungs (Figure 1B) and their counts in NA were
significantly decreased (P < 0.01) compared to controls
(UA: 10 385 ± 2724; DZ: 21 335 ± 10 587; NA: 603 ±
1376; control 18 708 ± 3454 expressed as 103 macro-
phages per g of lung tissue). Moreover, the macrophages
in NA resembled the CD163 and CD14 expression pat-
tern of monocytes in NA rather than that of macro-
phages in UA and DZ of the lungs (Figure 1B)
suggesting, in accordance with our previous data [19],
that the macrophages in NA of lungs developed from
recruited monocytes after the original population of pul-
monary macrophages completely disappeared.
Localization of CD14low/CD163+ monocytes within
tracheobronchial lymph nodes, spleen and mesenteric
lymph nodes
In order to ascertain localization of CD14low/CD163+
monocytes within TBLN and the spleen, immunohisto-
chemical staining of the CD163 molecule in these tissues
was performed. Although no monocytes were detected
in TBLN of control pigs by flow cytometry, the immuno-
histochemistry revealed numerous CD163+ cells within
the subcapsular sinus of TBLN (Figure 2A). These cells
were relatively large with abundant cytoplasm and
expressed the CD172a molecule (data not shown)
Table 1 Primers for chemokines, chemokine receptors, CD62L and reference gene used in quantitative real-time PCR.
Gene Alternative
name
Primer forward / reverse Tm Length of
product
CCL1 I-309 CCGTGGTTCTGGTGTGCCTGCTG / ACATGCATGCTCTTGCTGTCCACCT 68.19/67.01 70
CCL2 MCP-1 CCGAAGCTTGAATCCTCATC / TAGCAGCAGGTGACTGGAGA 56.30/60.25 134
CCL3-like1 MIP-1αS TTTTGAGACCAGCAGCCAGT / TCAGCTCCAGGTCAGAGATG 59.82/58.52 122
CCL4 MIP-1β GCTCCCAGCCAGCCGTGGTATTC / CAGTCATCACTGGGGTTGGCGCA 67.64/67.50 70
CCL5 RANTES ACCACACCCTGCTGTTTTTC / GGCGGTTCTTTCTGGTGATA 58.89/57.60 124
CCL8 MCP-2 CAGTGTCCCCAGGAGGCTGTGATCTTC / GTCCGCGCAGACCTCCTTGTCG 68.18/67.74 60
CCL11 Eotaxin TCCCCAGAATGCTGTGATCTTCAGCAC /
GGTCCAGGTACTCCATGGCATTCTGAACC
66.79/68.35 98
CCL17 TARC CTCCTCCTGGGGGCTTCCCTGC / CAGCACTCCCGGCCCACGTTG 68.64/68.37 68
CCL19 ELC CCACGCTGAAAGGTCGCGAGCTC / TTGCGGTGGTGCTTGCTCTTAGC 68.18/66.13 106
CCL20 MIP-3α TGCAGCAAGTCAGAAGCAGCAAGC / CGAGCTGCTGTGTGAAGCCCATG 66.60/66.44 100
CCL21 SLC CCCCCACACCCAAGGCAGTGATG / AACCCAGGCTTGGCTCCTGCTTC 67.60/67.31 116
CCL22 MDC TCAGACTCCTGCCGGAGGCCTG / CAGGGCAGTCTGGGGTCAGCAC 67.96/67.30 80
CCL25 TECK TTCTTCCAAGGCCCTCAGTCTGGAGTGA / ACTGTGGGCTCATGGTCCTGGAATAGC 68.56/68.05 147
CCL27 CTACK CCAGGCCTTCGTGCTTCACCTGTC / TCCCCTGGAGCCTCCTTCCATGG 67.69/67.54 104
CCL28 MEC GAAGCTATACTTCCCATTGCCTCCAGCT / TGCGCTTGACATGAAGGATGACAGCA 66.27/67.17 148
CXCL9 Mig AGCAGTGTTGCCTTGCTTTTGGGTATCATC /
GCTGGTGTTGATGCAGGAACAACGTCC
67.76/68.40 102
CXCL10 IP-10 CCCACATGTTGAGATCATTGC / CATCCTTATCAGTAGTGCCG 57.57/55.44 168
CXCL11 I-TAC ACAAAACAGAAGTGATTGTCACCCTGAAAGCAC /
GCTTGCTTTGATTTGGGATTTAGGCATCTTCGT
67.68/67.90 73
CXCL12 SDF-1α/β CCTCGTGCTGACCGCGCTCTG / CGAGAGAGTGGGACTGGGTTTGTTTAAAGCT 68.06/68.07 256
CXCL14 BRAK CGGCCAGCATGAGGCTCCTGAC / ACTTGCATTTGGACCCGTCCACGC 67.66/68.16 87
CXCL16 SR-PSOX TCGCGGAGAATGTGGACGTGCTC / TCGTCTGGGCAGGGGTGCTACTG 67.20/68.13 128




CCR2 TGCCACTTGGAAGAAGCAACAGACCG / CAGAGAGTGAGATGTGGGCAGCACG 67.54/67.21 100
CCR3 TCCCCATCAACGGGAGAGCAGGA / CTTCAGAGCTTCAGTGCTGTGCTGG 67.16/65.93 137
CCR4 GCCATTGTGCACGCGGTCTTCTC / GTGAAGCGAACACAGCCACCGAC 66.91/66.55 97
CCR5 TGGTCAGAGGAGCTGAGACA / AGAAGGGACTCGTCGTTTGA 59.89/58.67 86
CCR6 AGCGAGAGGGCGCTGGGCTAC / GTTGAGGCAGCAGTGCAGGAACG 68.88/66.60 69
CCR7 GTGGTGGCTCTCCTTGTCAT / GAAGCACACGGACTCGTACA 59.67/60.04 114
CCR9 CCACAGAAGCCGCAAGTCTGATGC / TGGCTTGCAAACTGCCTGACATGGT 66.45/67.64 139
CCR10 CTGCAGCTGCCCTACAGTCTCGC / AGATCCTTGCGCTTGCTGGCAGG 67.54/67.85 95




CXCR6 CCACTGACAGAGCACCTCTACTGGGTC / CCCCTGGCTGCTGTCGTTGGAAG 67.67/67.77 106
CX3CR1 CCAGTCACCTGCTGGCAACCCTACC / GGAAGCTGGTTTTGGGCTCTGGCTC 68.98/67.96 88
CD62L AGCTTCTTGTCAGCCCAGGTCATGC / CCCAGAGGCTCACACTGAGTCACGAAC 67.25/68.46 132
CD163 CTTGGGGCAGCGTTGGCAGGAATAG / ATGCAGGGCTGATGTCCCCTCTGTC 68.02/68.16 99
SLA-DR TGCTTGGAGTGTCACCATCTG / GGTCTGCTCTTTGTTGCTGTG 60.27/60.00 115
TBP1 AACAGTTCAGTAGTTATGAGCCAGA / AGATGTTCTCAAACGCTTCG 59.75/56.48 153
HPRT GAGCTACTGTAATGACCAGTCAACG / CCAGTGTCAATTATATCTTCAACAATCAA 61.41/58.88 111
Ondrackova et al. Veterinary Research 2013, 44:98 Page 6 of 16
http://www.veterinaryresearch.org/content/44/1/98
Table 2 Monocyte subpopulations in various body compartments from control and APP-infected pigs.
CD163- CD163+ % CD163+
n Control APP-infected Control APP-infected Control APP-infected
Bone marrow 5 1571 ± 118 464 ± 83** 1020 ± 161 1430 ± 142 38.6 ± 2.7 75.2 ± 4.3**
Peripheral blood 5 418 ± 61 184 ± 44* 418 ± 111 1142 ± 255* 47.1 ± 6.9 86.2 ± 0.5**
Spleen 4 3009 ± 916 1052 ± 273* 3524 ± 1,043 10 886 ± 3359 54.8 ± 9.6 90.0 ± 1.8*
Lungs
Unaffected area 5 1459 ± 336 735 ± 225* 3384 ± 702 7555 ± 1493* 69.0 ± 7.4 90.9 ± 2.1**
Demarcation zone 4 985 ± 467 11 890 ± 4331 90.4 ± 3.8*
Necrotic area 5 2873 ± 1,441 5948 ± 2232 66.2 ± 6.0
Tracheobronchial LN 5 n.d. 1547 ± 674* n.d. 16 563 ± 4284* n.d. 92.9 ± 1.7
Mesenteric LN 4 n.d. n.d. n.d. n.d. n.d. n.d.
The data are shown as total count × 103 of monocyte subpopulations per g of tissue of per mL of PB or as a percentage of CD163+ monocytes from CD163+ and
CD163- monocytes as measured by flow cytometry. Data are expressed as mean ± S.E.M. The significant differences (Mann–Whitney U test) between control and
APP-infected pigs are marked with *P < 0.05, **P < 0.01. The values which were elevated between control and APP-infected pigs are highlighted in bold. LN, lymph
node, n.d, non-detected.
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phages. The discrepancy between data from flow cytom-
etry and immunohistochemistry can be explained by the
fact that the LN leukocytes for flow cytometry analysis
were isolated by simple disintegration of the tissue.
Therefore, it is probable that macrophages were not
harvested by this procedure because they are tightly
fixed in the tissue. When immunohistochemical staining
of the CD163 molecule in TBLN from APP-infected pigs
was compared with the control ones, it was revealed that
abundant CD163+ cells massively infiltrated the cortex
and paracortical zone of TBLN (Figure 2B). These cells
were also found within the follicles but rarely.
Immunohistochemical staining of the spleen show no
differences in localization of CD163+ cells between con-
trol and APP-infected pigs. The occurrence of CD163+
cells was limited to the red pulp and marginal zone only
(Figure 2C, D). CD163+ cells in the marginal zone were
present as single events and probably represented mar-
ginal zone macrophages rather than monocytes.
Immunohistochemical staining of MLN revealed that
there were, similarly to TBLN from control pigs, CD163+
cells within the MLN simus in both control and APP-
infected pigs, which represent macrophages of the sub-
capsular sinus. According to flow cytometry results, no
monocytes within cortex and paracortex were found in
control or APP-infected pigs (data not shown).
Intensity of CD163, CD14 and SLA-DR molecule
expression by CD14low/CD163+ monocytes in various
organs
In order to reveal potential relationships among CD14low/
CD163+ monocytes in various tissues, the MFI of CD163,
CD14 and SLA-DR molecule expression was evaluated
in CD14low/CD163+ monocytes from BM, PB, spleen,
lungs and TBLN of control and APP-infected pigs
(Figure 3).The MFI of CD163, CD14 and SLA-DR sharply dif-
fered between control and APP-infected pigs. As it was
already apparent from Figure 1, the “inflammatory”
CD14low/CD163+ monocytes from APP-infected pigs
expressed significantly more CD163 and CD14 and less
SLA-DR than their “steady-state” counterparts from
control pigs. The MFI of SLA-DR expression in APP-
infected pigs was very low and corresponded to the MFI
of SLA-DR-negative cells.
On the contrary, what was not apparent from Figure 1
is that some differences in MFI of CD163, CD14 and
SLA-DR in CD14low/CD163+ monocytes occurred, also
among individual organs (see Kruskal-Wallis test in
Figure 3). The order of organs in Figure 3 was created
according to the known ways of monocyte migration
through particular organs in the mouse model. As sum-
marized in the introduction, monocytes leave the BM
and after circulation in PB they settle in the spleen.
From PB or alternatively from the spleen, they migrate
to the inflamed tissues. Then, from the inflamed tissues
or alternatively from PB they enter the LN.
The expression of CD163 was unchanged in mono-
cytes from control as well as from APP-infected pigs
with the exception of NA of the lungs where CD163 ex-
pression was down-regulated.
On the contrary, CD14 expression continuously in-
creased dependently on the supposed way of monocyte
apearance within organs, suggesting that porcine mono-
cytes could follow the same way of migration as mouse
monocytes do. This increase was more pronounced in
“inflammatory” monocytes. The CD14 MFI of spleen
“inflammatory” monocytes was on the half-way between
the PB and lungs. We can speculate that, as in the
mouse, PB monocytes could come into the spleen before
they enter the inflamed tissue. Moreover, MFI of CD14
in “inflammatory” monocytes from TBLN was signifi-
cantly elevated compared to PB, while no significant





























Figure 2 Representative pictures of immunohistochemical detection of CD163+ cells in tracheobronchial lymph node and spleen.
CD163+ cells were detected in tracheobronchial lymph nodes from control (A) and APP-infected pigs (B) and in spleen from control (C) and
APP-infected pigs (D). Immunohistochemical visualization: horseradish peroxidase, brown substrate, hematoxylin counterstain; c, cortex; ca, central
artery; e, ellipsoid; f, follicle; mz, marginal zone; pals, periarterial lymphatic sheath, rp, red pulp; s, subcapsular sinus.
Ondrackova et al. Veterinary Research 2013, 44:98 Page 8 of 16
http://www.veterinaryresearch.org/content/44/1/98difference was observed between TBLN and the lungs,
suggesting that monocytes that infiltrate the TBLN are
rather recruited from inflamed lungs than from PB.
SLA-DR expression by “steady-state” monocytes was
sharply decreased between PB and the spleen, and PB
and the lungs. On the contrary, the expression was com-
parable between the spleen and lungs. We can speculate
that “steady-state” lung monocytes could be recruited ra-
ther from the spleen than from PB. However, it may also
reflect a down-regulation of SLA-DR expression after
appearance of monocytes in the tissues, independently
of whether or not they go to the tissues from PB through
the spleen.
Chemokine and chemokine receptor mRNA expression in
various organs
In order to elucidate which chemokines and their appro-
priate receptors could play a role in monocyte distribu-
tion during inflammation, the mRNA levels for all
porcine chemokines and their receptors, for which the
cDNA sequence is available, were measured in control
and APP-infected pigs. The mRNA level of porcine
chemokines was measured in BM, lungs, TBLN, spleen
and MLN.
It was found that the mRNA for CCL3, CCL8 and
CCL19 was significantly up-regulated in BM from APP-
infected pigs (Table 3). Many of the evaluatedchemokines were elevated to high levels in NA com-
pared to UA and DZ of the lungs. On the contrary, only
a few of them, namely CCL3, CCL4 and CCL19 or
CCL3, CCL19 and CXCL14 were found to be slightly el-
evated in UA or DZ of lungs, respectively (Table 3). In
TBLN, the CCL3, CCL4, CCL19, CXCL14 and CXCL16
were elevated (Table 3). It should be added that, espe-
cially in TBLN, many chemokines were down-regulated
in APP-infected pigs. Namely CCL17, CCL21, CCL25,
CCL28, CXCL9, CXCL10, CXCL11 and CXCL12 mRNA
were decreased suggesting that these chemokines may
play a homeostatic role during the steady-state condi-
tions in pigs. Surprisingly, although “inflammatory”
monocytes were detected in the spleen of APP-infected
pigs, none of the measured chemokines was found to be
increased in the spleen (data not shown). Neither che-
mokine was found to be increased in the MLN; this was
in accordance with the fact that monocytes were not
found in MLN from APP-infected pigs. The only excep-
tion was CXCL14, which was slightly, but significantly
up-regulated (data not shown). Generally, the levels of
chemokine mRNA in MLN resembled the levels in
TBLN from control pigs.
It should be highlighted that the levels of CCL19
mRNA in TBLN and MLN from control pigs were nat-
urally high compared to other tissues, reaching more
that 10-times higher levels. These high levels were not,
Figure 3 Intensity of CD163, CD14 and SLA-DR expression by CD14+/CD163+ monocytes in various body compartments. Data are
shown as MFI (Median of fluorescence intensity) ± S.E.M. BM, bone marrow (n = 5); PB, peripheral blood (n = 5), UA, lungs-unaffected area (n = 5),
DZ, lungs-demarcation zone (n = 4), NA, lungs-necrotic area (n = 5), TBLN, tracheobronchial lymph node (n = 5); MLN, mesenteric lymph node
(n = 4), spleen (n = 4). The significant differences (Kruskal-Wallis test) amongst particular compartments are indicated.
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cytes in TBLN and MLN of control pigs suggesting that
CCL19 probably could not play a role at all in attracting
monocytes into LN.
It should be further highlighted that CXCL14 was up-
regulated in MLN from APP-infected pigs but this up-
regulation was also not accompanied by the appearance
of any monocytes. Although the timing of the infection
could influence the appearance of monocytes in MLN,
this calls into question the role of CXCL14 in attracting
“inflammatory” monocytes into LN.
Various chemokines were found to be elevated in BM,
lungs and TBLN of APP-infected pigs. Accordingly, the
principle of chemokine-mediated attraction of cells into
the tissues is based on interactions of chemokines with
chemokine receptors expressed by the cells; the level of
mRNA for chemokine receptors was evaluated in BM
and PB CD163+ monocytes, in NA of lungs and in
TBLN.
BM and PB CD163+ monocytes expressed relatively
high levels of CCR1, CCR3, CCR4, CCR10, CXCR3,
CXCR4 and CX3CR1 (Table 4) compared to CCR2,
CCR5 and CCR7, which were expressed in relatively
lower levels. Other chemokine receptors (CCR6, CCR9,
and CXCR6) were undetectable or expressed at negli-
gible levels. Generally, if any differences were found in
chemokine receptor mRNA expression between BM and
PB monocytes, the expression in PB was always up-
regulated. The main expectation was that chemokine re-
ceptors, which are involved in chemotaxis of monocytes
into tissues during inflammation, should be up-regulated
in APP-infected pigs and, on the contrary, chemokine
receptors with homeostatic function should be down-
regulated. Surprisingly, if any differences were found in
chemokine receptor expression between control andAPP-infected pigs, the expression in APP-infected pigs
was always down-regulated. Due to this uniform down-
regulation of most chemokine receptors, the stability of
the HPRT gene was proven by measurement of another
commonly used reference gene TBP1. No significant dif-
ferences in TBP1 expression in relation to HPRT were
observed (Table 4) suggesting that HPRT is stable
throughout all BM and PB CD163+ monocytes from
control and APP-infected pigs and the observed down-
regulation of most of the chemokine receptors is
correct.
The flow cytometry shows that CD163+ monocytes
from APP-infected pigs expressed more CD163 and less
SLA-DR protein compared to control pigs. Comparable
data were observed at mRNA level in PB monocytes and
in the tissues that had been infiltrated by these cells (i.e.
NA of lungs and TBLN, Table 4) verifying, at least partly,
that the data obtained at the mRNA level resemble the
expression at the protein level.
In the NA of the lungs, CCR1, CCR3, CCR4, CCR10
and CXCR4 were up-regulated in APP-infected pigs
compared to the lungs from control pigs (Table 5). In
TBLN, CCR1, CCR2, CCR3 and CXCR4 were up-
regulated in the APP-infected pigs compared to control
pigs (Table 5).
To obtain a comprehensive overview, we have drawn a
chart that summarizes the results of chemokines and
chemokine receptor mRNA expression in various organs
and in CD163+ BM and PB monocytes (Figure 4).
Beside chemokines, monocyte recruitment into in-
flamed tissues could also be controlled by the adhesion
molecule CD62L [13]. Therefore, CD62L mRNA expres-
sion was measured in BM and PB CD163+ monocytes,
in the lungs and in TBLN from control and APP-
infected pigs. Uniformly low levels of CD62L mRNA
Table 3 Chemokine expression in various organs from control and APP-infected pigs.
Bone marrow Lungs Tracheobronchial LN
Control APP-infected Control APP-infected Control APP-infected
Unaffected area Demarcation zone Necrotic area
CCL1 0.028 ± 0.018 0.050 ± 0.037 0.025 ± 0.006 0.013 ± 0.002 0.008 ± 0.002* 0.152 ± 0.055* 0.009 ± 0.001 0.007 ± 0.001
CCL2 0.195 ± 0.043 0.486 ± 0.183 1.799 ± 0.291 2.027 ± 0.394 2.785 ± 0.831 101.809 ± 25.084** 3.831 ± 0.228 5.296 ± 1.162
CCL3 0.117 ± 0.015 0.174 ± 0.026* 0.623 ± 0.121 2.149 ± 0.497** 1.521 ± 0.313* 148.299 ± 48.339** 0.240 ± 0.057 1.169 ± 0.307**
CCL4 0.103 ± 0.017 0.148 ± 0.024 0.805 ± 0.108 2.006 ± 0.451* 1.506 ± 0.458 57.529 ± 15.897** 0.291 ± 0.057 0.922 ± 0.158**
CCL5 0.015 ± 0.014 0.054 ± 0.000 2.610 ± 0.455 2.015 ± 0.322 1.259 ± 0.210 11.351 ± 1.899** 2.293 ± 0.481 1.540 ± 0.179
CCL8 0.099 ± 0.013 0.158 ± 0.024* 0.121 ± 0.023 0.110 ± 0.016 0.125 ± 0.012 0.428 ± 0.153 0.336 ± 0.080 0.380 ± 0.038
CCL11 0.003 ± 0.001 0.001 ± 0.000 0.002 ± 0.001 0.004 ± 0.002 0.007 ± 0.003 0.132 ± 0.032** 0.002 ± 0.001 0.006 ± 0.004
CCL17 0.000 ± 0.000 0.001 ± 0.000 0.033 ± 0.012 0.025 ± 0.006 0.021 ± 0.005 0.120 ± 0.031 0.715 ± 0.085 0.430 ± 0.080*
CCL19 0.183 ± 0.039 1.478 ± 0.690** 1.526 ± 0.097 3.689 ± 0.540** 3.813 ± 0.728* 39.163 ± 9.875** 45.957 ± 4.607 77.840 ± 7.874*
CCL20 0.000 ± 0.000 0.001 ± 0.000 0.009 ± 0.002 0.010 ± 0.002 0.019 ± 0.003 6.833 ± 1.846** 0.288 ± 0.046 0.736 ± 0.217
CCL21 0.016 ± 0.008 0.006 ± 0.001 0.976 ± 0.107 1.053 ± 0.166 1.147 ± 0.189 0.533 ± 0.138* 17.522 ± 2.483 6.464 ± 2.130**
CCL22 0.003 ± 0.001 0.002 ± 0.001 0.038 ± 0.013 0.024 ± 0.006 0.024 ± 0.004 0.153 ± 0.040* 0.673 ± 0.124 0.306 ± 0.049*
CCL25 0.007 ± 0.001 0.006 ± 0.001 0.013 ± 0.001 0.011 ± 0.001 0.013 ± 0.001 0.011 ± 0.001 0.010 ± 0.001 0.006 ± 0.001**
CCL27 0.000 ± 0.000 0.001 ± 0.000 0.002 ± 0.000 0.003 ± 0.000 0.002 ± 0.000 0.005 ± 0.002 0.001 ± 0.000 0.001 ± 0.000
CCL28 n.d. n.d. 0.036 ± 0.003 0.038 ± 0.013 0.045 ± 0.032 0.011 ± 0.003** n.d. n.d.
CXCL9 0.180 ± 0.026 0.141 ± 0.018 1.704 ± 0.180 1.186 ± 0.288 0.820 ± 0.197* 1.644 ± 0.740 4.188 ± 0.591 1.790 ± 0.225**
CXCL10 0.983 ± 0.222 0.996 ± 0.197 5.272 ± 0.425 3.685 ± 0.742 2.788 ± 0.545* 8.892 ± 4.605 6.644 ± 0.826 3.097 ± 0.531**
CXCL11 0.353 ± 0.209 0.036 ± 0.013 0.124 ± 0.037 0.072 ± 0.023 0.059 ± 0.017 0.457 ± 0.201 0.146 ± 0.038 0.030 ± 0.007**
CXCL12 1.061 ± 0.123 1.022 ± 0.224 0.378 ± 0.047 0.241 ± 0.034* 0.246 ± 0.040 0.453 ± 0.081 6.123 ± 0.842 2.024 ± 0.580**
CXCL14 0.794 ± 0.075 1.376 ± 0.322 1.935 ± 0.241 2.553 ± 0.381 4.312 ± 0.547* 35.412 ± 4.900** 2.961 ± 0.400 5.579 ± 0.586**
CXCL16 0.605 ± 0.058 0.372 ± 0.036* 3.371 ± 0.211 2.340 ± 0.106** 2.639 ± 0.343* 9.151 ± 0.881** 1.427 ± 0.092 2.510 ± 0.486**
CX3CL1 0.010 ± 0.004 0.025 ± 0.006 0.078 ± 0.017 0.044 ± 0.011 0.050 ± 0.010 0.639 ± 0.225* 0.106 ± 0.008 0.048 ± 0.016*
The data are shown as a fold change of chemokine mRNA expression in relation to the reference gene HPRT as measured by the RT-qPCR. Data are expressed as mean ± S.E.M. (Control: n = 6, APP-infected: n = 9). The
significant differences (Mann–Whitney U test) between control and APP-infected pigs are marked with *P < 0.05, **P < 0.01. The values which were elevated between control and APP-infected pigs are highlighted in















Table 4 Chemokine receptor, CD62L, CD163 and TBP1 expression by bone marrow and peripheral blood CD163+
monocytes from control and APP-infected pigs.
Bone marrow Peripheral blood
Control APP-infected Control APP-infected
CCR1 0.87 ± 0.12 * 0.47 ± 0.07 * 0.87 ± 0.13 1.09 ± 0.30
CCR2 0.35 ± 0.07 * 0.18 ± 0.02 * 0.23 ± 0.08 0.11 ± 0.03
CCR3 4.42 ± 1.00 *† 1.86 ± 0.62 *‡ 18.79 ± 4.77 † 9.21 ± 4.28 ‡
CCR4 3.24 ± 0.71 *† 1.33 ± 0.41 *‡ 13.44 ± 3.25 † 6.42 ± 3.00 ‡
CCR5 0.16 ± 0.03 * 0.06 ± 0.01 *‡ 0.30 ± 0.05 0.15 ± 0.05 ‡
CCR6 n.d. n.d. n.d. n.d.
CCR7 0.46 ± 0.12 † 0.26 ± 0.05 0.88 ± 0.17 0† 0.24 ± 0.10 0
CCR9 0.003 ± 0.001 0.001 ± 0.000 0.006 ± 0.002 0 0.001 ± 0.000 0
CCR10 2.62 ± 0.54 *† 1.09 ± 0.31 *‡ 10.54 ± 2.26 0† 4.86 ± 2.00 0‡
CXCR3 2.55 ± 0.55 *† 1.00 ± 0.29 *‡ 10.83 ± 2.58 † 5.10 ± 2.27 ‡
CXCR4 3.81 ± 0.38 *† 2.04 ± 0.15 *‡ 8.70 ± 0.68 † 9.05 ± 1.82 ‡
CXCR6 0.002 ± 0.001 *† 0.000 ± 0.000 * 0.019 ± 0.008 0† 0.001 ± 0.000 0
CX3CR1 2.96 ± 0.63 † 1.18 ± 0.31 ‡ 13.01 ± 3.05 † 6.33 ± 2.33 ‡
CD62L 0.81 ± 0.20 0.86 ± 0.21 0.77 ± 0.32 1.29 ± 0.27
CD163 5.31 ± 0.52 *† 9.08 ± 2.27 *‡ 11.98 ± 2.55 † 19.40 ± 2.43 ‡
SLA-DR 16.62 ± 2.77 *† 4.43 ± 0.76 * 40.60 ± 4.04 0† 4.23 ± 1.23 0
TBP1 0.06 ± 0.01 0.06 ± 0.01 0.09 ± 0.02 0.11 ± 0.02
The data are shown as a fold change of chemokine receptor, CD62L, CD163, SLA-DR and TBP1 reference gene mRNA expression in relation to the reference gene
HPRT as measured by the RT-qPCR. Data are expressed as mean ± S.E.M. (n = 5). The significant differences (Mann-Whitey U test, P < 0.05,) between control and
APP-infected pigs are marked with * (bone marrow) or 0 (peripheral blood). The significant differences (Mann–Whitney U test, P < 0.05) between bone marrow and
peripheral blood monocytes are marked with † (control) or ‡ (APP-infected). The values which were elevated between control and APP-infected pigs are
highlighted in bold. N.d, non-detected.
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(Table 4). On the contrary, CD62L expression was
strongly elevated in the NA of lungs and in TBLN from
APP-infected pigs (Table 5) suggesting that CD62L mol-
ecule could play a role in control of cell appearance in
the inflamed tissue and LN. However, it is not clear
whether or not this principle is utilized just by “inflam-
matory” monocytes, since they expressed only low levels
of CD62L mRNA when they were present in the PB.
Discussion
The present study shows that monocyte counts in vari-
ous organs changed during inflammation. Our previous
study revealed that monocytes apeared in the inflamed
lungs during APP-induced pleuropneumonia [19]. The
present study extends our knowledge about the distribu-
tion of monocytes during inflammation. In accordance
with our previous data the CD163+ monocyte counts
were found to be significantly increased in PB, UA of
lungs and in TBLN from APP-infected pigs suggesting
that monocytes migrate just to these organs. On the
contrary, the numbers of these monocytes did not
change in BM, DZ and NA of the lungs and in the
spleen. The fact that no change occurred in the BM
monocyte count can be simply explained by enhancedemigration of newly generated BM monocytes into other
organs as described previously [19]. However, the ques-
tion arises as to whether monocytes migrated to DZ and
NA of the lungs and into the spleen during APP infec-
tion when their counts were unchanged. The analysis of
CD163, CD14 and SLA-DR expression shows that
CD163+ monocytes from APP-infected pigs shared a
relatively uniform phenotype in all evaluated organs.
This phenotype was completely different from the
phenotype of CD163+ monocytes from control pigs.
This suggests that original “steady-state” monocytes
disappeared from tissues and were replaced with a
novel population, which could be called “inflammatory”
and which is characterized by a high CD163 expression,
increased CD14 expression and an almost non-occurring
SLA-DR expression. Therefore, it is probable that mono-
cytes were not found to be elevated in DZ and NA of
the lungs and in the spleen because the loss of the
“steady-state” and appearance of “inflammatory” mono-
cytes was in balance.
The possibility that “inflammatory” CD14low CD163+
monocytes arise from “steady-state” CD14low CD163+ or
CD14hi CD163- monocytes was also taken into account
during evaluation of the data. We have no direct evi-
dence that this does not occur, however, there was a
Table 5 Chemokine receptor, CD62L and CD163 expression in lungs from control and APP-infected pigs.
Lungs Tracheobronchial LN
Control APP-infected (necrotic) Control APP-infected
CCR1 0.260 ± 0.021 5.462 ± 1.152** 0.091 ± 0.014 1.930 ± 0.673**
CCR2 0.070 ± 0.009 0.087 ± 0.015 0.076 ± 0.008 0.174 ± 0.029*
CCR3 0.163 ± 0.018 2.574 ± 0.594** 0.198 ± 0.055 0.738 ± 0.158**
CCR4 0.054 ± 0.013 0.494 ± 0.180* 0.333 ± 0.058 0.244 ± 0.055
CCR5 0.189 ± 0.016 0.324 ± 0.071 0.085 ± 0.007 0.175 ± 0.052
CCR6 n.d. n.d. n.d. n.d.
CCR7 0.055 ± 0.010 0.094 ± 0.021 1.748 ± 0.215 1.386 ± 0.293
CCR9 0.051 ± 0.007 0.030 ± 0.004* 0.181 ± 0.014 0.130 ± 0.015
CCR10 0.021 ± 0.002 1.205 ± 0.411** 0.015 ± 0.002 0.021 ± 0.003
CXCR3 0.206 ± 0.034 0.719 ± 0.255 0.550 ± 0.044 0.290 ± 0.047**
CXCR4 0.792 ± 0.132 1.798 ± 0.296** 0.825 ± 0.052 2.628 ± 0.328**
CXCR6 0.157 ± 0.029 0.047 ± 0.011** 0.100 ± 0.013 0.083 ± 0.015
CX3CR1 0.338 ± 0.038 0.704 ± 0.252 0.115 ± 0.012 0.101 ± 0.017
CD62L 0.83 ± 0.08 35.55 ± 9.82** 3.75 ± 0.202 13.21 ± 2.618**
CD163 1.54 ± 0.11 5.85 ± 1.20** 1.67 ± 0.507 14.81 ± 2.561**
The data are shown as a fold change of chemokine receptor, CD62L and CD163 gene mRNA expression in relation to the reference gene HPRT as measured by
the RT-qPCR. Data are expressed as mean ± S.E.M. (Control: n = 6, APP-infected: n = 9). The significant differences (Mann–Whitney U test) between control and APP-
infected pigs are marked with *P < 0.05, **P < 0.01. The values which were elevated between control and APP-infected pigs are highlighted in bold. LN, lymph
node; n.d, non-detected.
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as well as relatively high numbers of “inflammatory”
monocytes which strongly exceeded the numbers of
those “steady-state” ones.
In the extensively used mouse model, one specific sub-
set of monocytes, which is characterized by high levels
of Ly-6C molecule expression, is released from PB
[16,28] or from the spleen [9] to the site of acute inflam-
mation. In mice, there is no known information
concerning the phenotype of this subset which somehow
changes between the steady-state and inflammatory con-
ditions. From this point of view, the pig is completely
different because the CD14low/CD163+ “steady-state”
monocytes are replaced by the phenotypically distinct
“inflammatory” subset during APP infection.
Levels of mRNA for various chemokines and chemo-
kine receptors were found to be changed in lymphoid
tissue, lungs and monocytes. Although we cannot ex-
clude that mRNA expression for some chemokine recep-
tors can be turned down to a basal level after entry of
monocytes into the tissues in our time-point, i.e. 18 h
after infection, only chemokine receptors with up-
regulated mRNA expression were considered to play a
role in recruitment of monocytes. Thus the following
strategy for a biological interpretation of the data was
suggested: if expression of a chemokine in an inflamed
tissue was found to be up-regulated and the chemokine
plays a role in attracting monocytes to the tissue, it
could be assumed that at least one of the appropriatechemokine receptors should be expressed by these
monocytes. After monocytes had appeared in the tissue,
the mRNA for this/these chemokine receptor(s) should
be up-regulated in the tissue. The last presumption was
supported by the evaluation of CD163 mRNA expression
in PB monocytes and in the tissue which was infiltrated
by these cells (i.e. NA of lungs and TBLN). As described
above, “inflammatory” monocytes from PB expressed
high levels of CD163 mRNA. Accordingly, CD163
mRNA was strongly elevated in the NA of the lungs and
in TBLN.
The present study indicates that, after APP infection,
“inflammatory” monocytes originating in BM appeared
in various organs. Since chemokines that are responsible
for monocyte emigration are produced directly in the
BM [10], we evaluated chemokines expressed in BM and
appropriate chemokine receptors expressed by CD163+
BM monocytes. The CCL3, CCL8 and CCL19 were up-
regulated in BM of APP-infected pigs. BM monocytes
expressed chemokine receptors appropriate to these
chemokines, although it should be noted that the levels
of expression were relatively lower. Therefore, we can
hypothesize that any of these chemokines could possibly
initiate a release of BM monocytes to the bloodstream.
In the mouse model, the CCL2 expression in the BM
and CCL2/CCL7-CCR2 signaling plays a fundamental
role in monocyte emigration from the BM under inflam-
matory conditions [10,15]. Our results suggest that
CCL3, CCL8 or CCL19 could be responsible for this
Figure 4 Scheme of chemokines and corresponding chemokine receptor mRNA expression in various organs and CD163+ monocytes.
Chemokines in bone marrow, necrotic area of the lungs and tracheobronchial lymph nodes and chemokine receptors in necrotic areas of the
lungs and tracheobronchial lymph nodes which were up-regulated in the APP-infected pigs compared to control are highlighted in bold.
Chemokine receptors in bone marrow and peripheral blood CD163+ monocytes which were expressed at relatively lower levels are highlighted
in bold. Those expressed in relatively high levels are highlighted in bold and underlined. Arrangement of the scheme was created based on the
review of Bonecchi et al. [27].
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regulated in BM from APP-infected pigs, on the contrary
to the findings in the mouse model. The finding closely
correlates with the fact that porcine and mouse mono-
cyte subsets, which participate in the acute phase of in-
flammatory response in each of these species, feature
different CCR2 expression. In the mouse, these Ly-6Chi
monocytes typically express high levels of CCR2 [17].
On the contrary, porcine “steady-state” as well as “in-
flammatory” CD163+ monocytes in control and APP-
infected pigs express very low levels of CCR2 and, more-
over, it is known that they are not attracted by CCL2
in vitro [29].
The present study shows that, as well as in the mouse
[9], porcine spleen contained high numbers of mono-
cytes. Moreover, similarly to the mouse, the proportion
of particular spleen monocyte subpopulations resembled
those in PB under steady-state conditions. In the mouse,
the spleen functions as an important reservoir of mono-
cytes [9,14]. During inflammation, monocytes are rapidly
released from this niche to the inflamed tissues and the
total number of splenic monocytes rapidly decreases by
one half [14]. In pigs, the splenic “steady-state” CD163+
monocytes also disappeared from the spleen; however,
they were substituted by “inflammatory” CD163+ mono-
cytes. Based on the analysis of the intensity of CD14 andSLA-DR molecule expression, we can speculate that,
similarly to mice, PB monocytes migrate to the spleen
before they enter the target tissue. Further experiments,
using in vivo tracking methods, are planned in the future
to reveal the role of the spleen in monocyte trafficking.
Similarly to the mouse [9], monocytes were localized
in the red pulp of the spleen only. Since they were not
found within the white pulp of the spleen in either
control or APP-infected pigs, it could be supposed
that they probably do not influence the specific
immune response within the spleen by e.g. presenting
the antigen to T cells, as described in LN draining the
inflamed tissue [2,4].
Although the spleen is primarily a reservoir of mono-
cytes in the mouse, in the case of certain specific dis-
eases such as malaria, monocytes migrating to the
spleen could play a role in the control of this disease [8].
Since this migration is modulated by certain chemokines
[30] we evaluated chemokine expression in the spleen
from APP-infected pigs. We found that although “in-
flammatory” monocytes appeared in the spleen in APP-
infected pigs, neither of the evaluated chemokines was
elevated suggesting that chemokines are probably not in-
volved in monocyte migration to the spleen.
The proportions of particular monocyte subpopula-
tions in the spleen resembled those in the PB from
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spleen is an organ which naturally contains high
amounts of blood, it should therefore be discussed as to
whether monocytes found in the spleen are not only an
artifact. The total numbers of CD163+ monocytes shows
that 1 g of splenic tissue contains almost ten-times the
amount of monocytes in 1 mL of PB. Since 1 mL of PB
weighs approximately 1 g, it can be concluded that the
numbers of splenic monocytes greatly exceed their num-
bers in the PB and therefore, they are probably settled in
the spleen and their presence is not an artifact. The
exact role and fate of splenic monocytes in pigs is, how-
ever, unknown.
It was also demonstrated in the present study that “in-
flammatory” CD163+ monocytes appeared in the lung
tissue after APP-infection. In NA of the lungs, different
chemokines were up-regulated. However, CCL3, CCL5,
CCL11 and CCL22 were the only chemokines whose at
least one of appropriate receptor (CCR1, CCR3 or
CCR4) was up-regulated. So, they could probably play a
role in attracting cells to the inflamed tissue. As men-
tioned before, monocytes arrive at the site of inflamma-
tion from the PB or spleen. All the receptors, which
were elevated in NA of the lungs (CCR1, CCR3, CCR4,
CCR10 and CXCR4) were expressed at high levels also
by PB monocytes, suggesting that any of the above men-
tioned chemokines could play a role in attracting mono-
cytes to the NA of the lungs. CCR10 and CXCR4 were
elevated in the NA of the lungs, although all known li-
gands for these chemokines (CCL27 and CCL28 or
CXCL12, respectively) were not increased. This elevation
was probably caused entirely by the fact that monocytes
infiltrating the site of inflammation expressed these re-
ceptors, although they did not use them for chemotaxis.
It is to be noted that although mRNA for chemokine re-
ceptors, expressed by infiltrating monocytes, probably
influences the expression of the chemokine receptors
CXCR3 and CX3CR1, which were also expressed at high
levels by PB monocytes, was not elevated in NA of the
lungs. A possible explanation is that monocytes attracted
to the inflamed tissue down-regulate mRNA for CXCR3
and CX3CR1 when moving from PB to the inflamed tis-
sue. Additionally, CCL1 and CXCL14 were also up-
regulated in the NA of the lungs. Biological relevance of
this feature cannot be further confirmed, because the
cDNA sequence for CCR8, which is the receptor for
CCL1, is not available and the receptor for CXCL14 is
generally unknown.
The present study also shows that high numbers of
monocytes appeared in TBLN after APP infection. Al-
though various chemokines were up-regulated in TBLN,
the only CCL3 with the up-regulated appropriate recep-
tor CCR1 probably plays a role in attracting cells to the
inflamed tissue. As mentioned above, the receptor forCXCL14 is generally unknown, and therefore, we cannot
decide whether this receptor plays a role in monocyte
migration or not. However, CXCL14 was up-regulated in
MLN from APP-infected pigs but this up-regulation was
not accompanied by the appearance of any monocytes.
From this perspective, it seems less likely that CXCL14
played a role in attracting “inflammatory” monocytes
into inflamed tissues.
It should be noted that CCR2, CCR3 and CXCR4 re-
ceptors were also up-regulated, but none of the mea-
sured ligands was elevated. However, a role of CCR2 and
CCR3 in monocyte migration to the TBLN could not be
excluded because these receptors bind a range of various
other pro-inflammatory chemokines. These chemokines
were unfortunately non-measurable due to the unavail-
ability of cDNA sequences for these chemokines in pigs.
Migration of monocytes into LN in mice is driven by
CCL19/CCL21-CCR7 signaling [4,7] or by CCL3, CCL4
and CXCL9 [12]. Our study shows that, unlike in mice,
CCL3 and its appropriate receptor CCR1 are probably
involved in monocyte attraction to the LN during in-
flammation in pigs. Although CCL4 and CCL19 were
also found to be up-regulated in TBLN from APP-
infected pigs, the corresponding receptors (CCR5 and
CCR7 respectively) were unchanged in TBLN. Generally,
high steady-state expression of CCL19 in the lymph
node is known to be responsible for homeostatic
lymphocyte migration [31]. Since high CCL19 expression
in TBLN from control pigs was not accompanied by
monocyte appearance, it could therefore be presumed
that, in contrast to mice, CCL4 and CCL19 probably do
not play a role in monocyte recruitment to LN draining
the inflamed tissue.
It is not clear from the present study as to what is the
origin of “inflammatory” TBLN monocytes in pigs. In
mice, monocytes migrate to the LN from inflamed tis-
sues via the lymphatic vessels [2,5,6] or from PB via high
endothelial venules (HEV) [2,12]. Although TBLN were
massively infiltrated with monocytes, the chemokine re-
ceptors which were elevated in TBLN (CCR1, CCR2,
CCR3, CXCR4) did not correspond with the profile of
chemokine receptors, which were highly expressed by
“inflammatory” monocytes in PB (CCR1, CCR3, CCR4,
CCR10, CXCR3, CXCR4 and CX3CR1). They rather re-
sembled the chemokine receptors which were elevated
in NA of the lungs infiltrated with “inflammatory”
monocytes (CCR1, CCR3, CCR4, CCR10 and CXCR4).
Based on the differences in the expression of chemokine
receptors, we can speculate that “inflammatory” mono-
cytes could arrive at TBLN from NA of the lungs rather
than from PB.
Our study revealed that, similarly to the mouse [4,5],
“inflammatory” monocytes accumulate in the cortex and
paracortex of LN suggesting that they could play a role
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However, the majority of studies in mice reported that
monocytes, which populate the LN during inflammation,
develop into monocyte-derived DC [4,13] exhibiting typ-
ical features of DC, such as high MHCII expression
already 12 hours after infection [4]. Our study, on the
contrary, revealed that “inflammatory” monocytes in
TBLN as well as in other organs after 18 h-lasting APP
infection exhibited uniformly low expression of a por-
cine MHCII antigen, the SLA-DR molecule. Therefore,
it is possible that monocytes infiltrating the TBLN of
APP-infected pigs could play a role since they are with-
out development into DC and similarly to very recent
findings in mice [7], they could be involved in cross-
presentation of antigens to cytotoxic T cells.
It could be concluded that different chemokines and che-
mokine receptor mRNA expression was changed in various
organs and cells during APP infection in pigs. Given to-
gether, only CCL3, CCL8 and CCL19 in BM, CCL1, CCL3,
CCL5, CCL11, CCL22 and CXCL14 in the necrotic area of
the lungs and CCL3 in TBLN could probably play a role in
monocyte attracting into these organs. The present study
shows for the first time that there are large differences in
phenotypical changes and distribution of monocytes during
inflammation between pigs and the widely used mouse
model.
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